Möchten Sie immer auf dem neuesten Stand bleiben?

Erstellen Sie noch heute ein Leserkonto, um die Branchen und Unternehmen zu verfolgen, die Sie interessieren, und passen Sie Ihr Nachrichten-Dashboard an.

Beim Leserkonto Anmelden Leserkonto Erstellen

19. Mai 2005 09:00 ET | Quelle: Greystone Medical Group, Inc.

FDA Clears Greystone Medical Group's Epi-Max for Sale in the U.S.

MEMPHIS, Tenn., May 19, 2005 (PRIMEZONE) -- Greystone Medical Group announced today that it has received U.S. Food and Drug Administration (FDA) clearance to market and sell Epi-Max(r), a wound care...
18. Mai 2005 17:43 ET | Quelle: Greystone Medical Group, Inc.

FDA Clears Greystone Medical Group's Epi-Max for Sale in the U.S.

MEMPHIS, Tenn., May 18, 2005 (PRIMEZONE) -- Greystone Medical Group announced today that it has received U.S. Food and Drug Administration (FDA) clearance to market and sell Epi-Max(r), a wound care...
24. Februar 2005 08:30 ET | Quelle: Greystone Medical Group, Inc.

U.S. DOD Funds Research on Hemorrhage-Stopping Drug

MEMPHIS, Tenn., Feb. 24, 2005 (PRIMEZONE) -- The U.S. Defense Department has awarded $750,000 to Greystone Medical Group and the University of Tennessee Health Science Center (UTHSC) to complete...